The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer.

Trends Cancer

Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Cantoblanco, Madrid E-28049, Spain. Electronic address:

Published: April 2019

Dysregulation of the PI3K/PTEN pathway is a frequent event in cancer, and PIK3CA and PTEN are the most commonly mutated genes after TP53. PIK3R1 is the predominant regulatory isoform of PI3K. PIK3R2 is an ubiquitous isoform that has been so far overlooked, but data from The Cancer Genome Atlas shows that increased expression of PIK3R2 is also frequent in cancer. In contrast to PIK3R1, which is a tumor-suppressor gene, PIK3R2 is an oncogene. We review here the opposing roles of PIK3R1 and PIK3R2 in cancer, the regulatory mechanisms that control PIK3R2 expression, and emerging therapeutic approaches targeting PIK3R2.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2019.02.009DOI Listing

Publication Analysis

Top Keywords

opposing roles
8
pik3r2
6
cancer
5
roles pik3r1/p85α
4
pik3r1/p85α pik3r2/p85β
4
pik3r2/p85β cancer
4
cancer dysregulation
4
dysregulation pi3k/pten
4
pi3k/pten pathway
4
pathway frequent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!